A non-receptor protein kinase Src plays a crucial role in fundamental cell functions such as proliferation, migration, and differentiation. While inhibition of Src is reported to contribute to chondrocyte homeostasis, its regulation at a subcellular level by chemical inhibitors and mechanical stimulation has not been fully understood. In response to inflammatory cytokines and stress to the endoplasmic reticulum (ER) that increase proteolytic activities in chondrocytes, we addressed two questions: Do cytokines such as interleukin 1 beta (IL1b) and tumor necrosis factor alpha (TNFa) induce locationdependent Src activation? Can cytokine-induced Src activation be suppressed by chemically alleviating ER stress or by applying fluid flow? Using live cell imaging with two Src biosensors (i.e., cytosolic, and plasma membrane-bound biosensors) for a fluorescence resonance energy transfer (FRET) technique, we determined cytosolic Src activity as well as membrane-bound Src activity in C28/I2 human chondrocytes. In response to TNFa and IL1b, both cytosolic and plasma membrane-bound Src proteins were activated, but activation in the cytosol occurred earlier than that in the plasma membrane. Treatment with salubrinal or guanabenz, two chemical agents that attenuate ER stress, significantly decreased cytokine-induced Src activities in the cytosol, but not in the plasma membrane. In contrast, fluid flow reduced Src activities in the plasma membrane, but not in the cytosol. Collectively, the results demonstrate that Src activity is differentially regulated by salubrinal/guanabenz and fluid flow in the cytosol and plasma membrane.
Introduction
Chondrocytes are a predominant cell type present in articular cartilage, whose integrity is jeopardized in joint degenerative diseases such as osteoarthritis (OA) [1] . In the chondrocytes [2] [3] [4] as well as the synovial tissues [5, 6] of patients with OA, the elevated level of inflammatory cytokines such as interleukin 1b (IL1b) and tumor necrosis factor a (TNFa) have been reported. These cytokines contribute to degrading cartilage matrix by increasing activities of proteolytic enzymes, including matrix metalloproteinases (MMPs) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) [7] . In addition to their contribution to proteolytic enzymes, these cytokines adversely affect anabolic activity of chondrocytes by inhibiting the production of proteoglycans and type II collagen [8, 9] . Therefore, blocking the action of these cytokines is a potential strategy to prevent cartilage degradation.
The articular cartilage is primarily subjected to compression, which results in complex mechanical stimuli including tissue deformation, fluid flow-induced shear stress, and hydrostatic pressure [10] . It has been reported that moderate, physiological mechanical loading contributes to maintenance of cartilage homeostasis (reviewed in [11, 12] ). Application of gentle loading, for example, is shown to inhibit IL1-induced matrix degradation [13] as well as expression of MMPs and ADAMTS [14, 15] . Importantly, integrin-dependent signaling is linked to IL1-induced signaling in chondrocytes [16] [17] [18] [19] . Src is one of the integrindependent signaling proteins involved in mechanotransduction [20] , and it plays critical roles in various cellular processes including proliferation, apoptosis, migration, adhesion, and differentiation [21] . To mediate such a variety of cellular processes, Src's distinct subcellular activation pattern is required. Src is mainly stationed in the cytosol near the endosomes [22] , and activation of Src requires its translocation to the plasma membrane [23] through the cytoskeleton [24] . While Src is known to regulate proliferation and differentiation of chondrocytes [25] , its responses to inflammatory cytokines and fluid flow, particularly at the subcellular level, have not been well understood.
In addition to cytokines and mechanical loading, cellular stress to the endoplasmic reticulum (ER) is known to affect chondrocyte functions [26] and expression of MMPs [27] . We have previously reported that salubrinal, a chemical agent that reduces ER stress [28] , inhibits IL1b-and TNFa-induced MMP activities by inhibiting dephosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2a) [29] . Phosphorylation of eIF2a plays a crucial role in regulating pro-survival cellular pathways. In response to various environmental stresses including ER stress, viral infection, and oxidative stress, eIF2a is phosphorylated for reducing global translation, allowing cells to activate a group of genes important for survival [30] . Although phosphorylation of eIF2a inhibits integrin-mediated signaling and subsequently reduce MMP activities in chondrocytes [29] , little has been known about the role of eIF2a in Src regulation.
In the present study, we investigated the role of eIF2a and mechanical force in Src activity in chondrocytes. In order to visualize subcellular activity pattern of Src in chondrocytes, we used live cell imaging in conjunction with two types of fluorescence resonance energy transfer (FRET)-based Src biosensors that selectively target lipid rafts of the plasma membrane and cytosol. IL1b and TNFa were used as inflammatory cytokines. Three levels of fluid flow were applied to the cells, and the role of mechanical stimulation in Src activity was examined. Salubrinal and guanabenz, the other agent that inhibits dephosphorylation of eIF2a, as well as siRNA specific to eIF2a were used to investigate the role of eIF2a in Src activity.
Materials and Methods

Src biosensors
FRET-based, cyan fluorescent protein (CFP)-yellow fluorescent protein (YFP) biosensors were used for monitoring Src activities in the cytosol (Cyto-Src) and lipid rafts of the plasma membrane (Lyn-Src) [31, 32] . The Cyto-Src biosensor consists of CFP, a binding domain of an effector protein (SH2 domain), a truncated Src substrate peptide and YFP (Fig. 1A) . The lipid rafts-targeted Src biosensor was produced by fusing acylation substrate sequences derived from Lyn kinase to the N-terminal of CytoSrc biosensor [31] . Src activation promotes the intramolecular binding of the SH2 domain to the truncated Src domain within the biosensor, which leads to a conformational change of the biosensor and the decrease of FRET efficiency from CFP to YFP (Fig. 1A) . Hence, Src activity can be visualized as changes of the emission ratio of the CFP/YFP. The specificity of the biosensors has been well characterized previously [31, 32] .
Chemical reagents and eIF2a siRNA
Two types of proinflammatory cytokines, TNFa (Sigma; 10 ng/ ml) and IL1b (Sigma; 1 ng/ml), were used. Salubrinal and guanabenz (both from Tocris Bioscience), inhibitors of eIF2a phosphatase, were used to test the effect of phosphorylation of eIF2a on Src activity [28, 33] . We also used eIF2a siRNA and non-specific control (NC) siRNA (Origene). Cytochalasin D (Sigma; 1 mg/ml) was used to disrupt actin filaments. Methylbeta-cyclodextrin (MbCD; Sigma; 10 mM) was used to extract cholesterol from the lipid rafts of the plasma membrane.
Cell culture, transfection, and Western blotting
The human chondrocyte cell line C28/I2 was used [34] . Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Lonza) containing 10% FBS (Hyclone) and 1% penicillin/ streptomycin (Lonza), and maintained at 37uC and 5% CO 2 in a humidified incubator. Neon transfection system (Invitrogen) was used to transfect Src biosensors into the cells. After transfection, the cells were transferred to a type I collagen-coated glass bottom dish or m-slide cell culture chamber (Ibidi) and incubated in DMEM containing 0.5% FBS for 24-36 h before imaging experiments. For Western blotting, cells were grown in the presence and absence of salubrinal or guanabenz and lysed in a radioimmunoprecipitation assay (RIPA) buffer. Isolated proteins were fractionated using 10% SDS gels and electro-transferred to Immobilon-P membranes. The membrane was incubated for 1 h with primary antibodies followed by 45 min incubation with secondary antibodies conjugated with horseradish peroxidase (Cell Signaling). We used antibodies against eIF2a (Cell Signaling), phosphorylated eIF2a (p-eIF2a; Thermo), and b-actin (Sigma). Signal intensities were quantified with a luminescent image analyzer (LAS-3000, Fujifilm).
Shear stress application
Fluid flow-induced shear stress has been shown to play a crucial role in the development and progression of osteoarthritis [35] . During imaging, a unidirectional flow was applied to the cells grown in the m-slide cell culture chamber (Ibidi) at 37uC [36, 37] . The chamber was perfused with HEPES-buffered (20 mM), phenol red-free DMEM without serum to maintain the pH at 7.4. Because the shear stress of 2-10 dynes/cm 2 has been shown to affect chondrocyte signaling and metabolism either positively or negatively [37] [38] [39] [40] , we used this flow range in this study. The shear stress was applied to the cells by controlling the flow rate of a peristaltic pump (Cole-Parmer). A pulse dampener (Cole-Parmer) was used to minimize pulsation of the flow due to the pump.
Microscopy and image analysis
Images were obtained by using a Nikon Ti-E inverted microscope equipped with an electron-multiplying charge-coupled device (EMCCD) camera (Evolve 512; Photometrics), a filter wheel controller (Sutter Instruments), and a Perfect Focus System (Nikon) that maintains the focus during time-lapse imaging. The following filter sets (Semrock) were used: CFP excitation: 438/24 (center wavelength/bandwidth in nm); CFP emission (483/32); YFP (FRET) emission: 542/27. To minimize photobleaching, cells were illuminated with a 100 W Hg lamp through an ND64 (,1.5% transmittance) neutral density filter. Time-lapse images were acquired at intervals of 2 min with a 406 (0.75 numerical aperture) objective. FRET images for Src activity were generated with NIS-Elements software (Nikon) by computing an emission ratio of CFP/YFP for individual cells over time. The FRET ratio images were scaled according to the color bar. To quantify the kinetics of the FRET responses of Src biosensors, the discrete time derivatives of the emission ratios, Y, were calculated and the associated curves were fitted using the Gaussian functions:
. The parameter A represents the maximal rate of FRET ratio change upon stimulation, m the time point where the rate of FRET ratio change reaches the maximal value, and s the duration of the rate of FRET ratio change. The rate of FRET ratio change in response to cytokines was assumed to follow a Gaussian distribution. This assumption was tested by the D'Agostino-Pearson (omnibus K2) normality test [41] .
Statistical analysis
Statistical data are presented as the mean 6 standard error of the mean (SEM). One-way ANOVA followed by Dunnett's post hoc test was used to determine the statistical differences. Student's t-test was used to compare two groups. Statistical analyses were conducted using Prism 5 software (GraphPad Software). p,0.05 was considered significant. In the time course data, * indicates the time point after which the Src activity becomes significantly different from that at 0 min.
Since Src can be activated at different subcellular locations [42] , we first tested whether Cyto-Src in the cytosol and Lyn-Src in the lipid rafts of the plasma membrane would be differently regulated by TNFa and IL1b. In C28/I2 human chondrocytes, Cyto-Src activities were increased by treatment of TNFa or IL1b and reached a maximal at 90 min by TNFa (10.0%) and at 80 min by IL1b (7.1%) (Fig. 1B) . Its activities after 10 min of the cytokine treatment were significantly different from those at time 0 (p, 0.05), and the activation level was maintained for 2 h. Lyn-Src activities were also increased by TNFa or IL1b, while they showed a slower increase than that of Cyto-Src (Fig. 1C) . The FRET ratio increased and reached the peak value at 120 min by TNFa (10.2%) and at 110 min by IL1b (11.6%). The Lyn-Src activities after 50 min of the cytokine treatment were significantly different from those at time 0 (p,0.05). We also observed that cytokineinduced Lyn-Src activities were initially decreased (Fig. 1C) . However, the decreased Src activity following cytokine treatment was not significantly different from that at 0 min.
Since the temporal profiles of Cyto-Src and Lyn-Src activities were different, we determined t K , which measured the time required for Src to reach the half-maximal activity level (Fig. 1D) . The result showed that the mean and standard deviation of t K of Cyto-Src (TNFa: 16.2562.63 min; and IL1b: 22.2266.24 min) were significantly lower than those of Lyn-Src (TNFa: 53.3365.87 min; and IL1b: 53.3363.23 min). To evaluate a rate of activation changes in response to TNFa and IL1b, we computed time derivatives of activation levels and the estimated rate was fitted to a Gaussian distribution function (Fig. 1E) . Based on the D'Agostino-Pearson (omnibus K2) normality test, the p values for all experimental conditions were higher than the cut-off value, 0.05, indicating that the data follow a Gaussian distribution. In the fitting, the rate of the changes in Cyto-Src reached the maximal earlier than that in Lyn-Src (Fig. 1E) , consistent with t K data (Fig. 1D) . Compared to Lyn-Src, Cyto-Src activities showed significantly lower mean time parameters in the Gaussian curves (Cyto-Src+TNFa: 17.5962.51; Cyto-Src+IL1b: 20.0267.78; LynSrc+TNFa: 60.1163.87; and Lyn-Src+IL1b: 63.1964.37). However, differences in the level and duration of Src activation were not statistically significant (Fig. 1F-G) .
Effects of actin cytoskeleton and lipid rafts on cytokineinduced Lyn-Src activation
Since activation of Src is associated with its translocation to the plasma membrane via the actin cytoskeleton [43] , we examined the roles of the actin cytoskeleton and lipid rafts in the responses to cytokines. Cells were pretreated with Cytochalasin D (CytoD) for 1 h to disrupt the actin cytoskeleton or with MbCD for 1 h to extract cholesterol from the plasma membrane. CytoD partially blocked Cyto-Src activation, and it completely inhibited Lyn-Src activation (Fig. 1H) . MbCD reduced both Cyto-Src and Lyn-Src activations, although to a lesser degree to Cyto-Src (Fig. 1H) . Collectively, these data suggest that the actin cytoskeleton and lipid rafts are essential components for cytokine-induced Lyn-Src activation (Fig. 1D-H) .
Inhibition of Cyto-Src by salubrinal and guanabenz
Western blotting revealed that incubation with salubrinal and guanabenz elevated the phosphorylation level of eIF2a by 4069% (p,0.01) and 29619% (p,0.05), respectively ( Fig. 2A-B) . Salubrinal decreased Cyto-Src activity in a dose-dependent manner (Fig. 2C) . Although a lower concentration (1 and 2 mM) did not detectably alter Cyto-Src activity, salubrinal at 5, 10, and 20 mM significantly decreased it (5 mM: 10.9%; 10 mM: 10.0%; and 20 mM: 11.7% after 60 min). Cyto-Src activities after 8 min were significantly different from those at 0 min (p,0.001). Guanabenz at 10 and 20 mM also decreased Cyto-Src activity, while lower concentrations did not affect it (10 mM: 9.7%; 20 mM: 10.1% at 60 min). Its activities after guanabenz treatment (4 min at 10 mM; 14 min at 20 mM) were significantly different from those at time 0 (p,0.001). In contrast to Cyto-Src, Lyn-Src activity was not altered either by salubrinal or guanabenz (Fig. 2D and Fig. S1 ).
In response to TNFa or IL1b, both salubrinal and guanabenz significantly reduced cytokine-induced Cyto-Src activities (Fig. 3A and Fig. S2 ), but they did not inhibit cytokine-induced Lyn-Src activation (Fig. 3B) .
Involvement of eIF2a in the inhibitory effect of salubrinal on Cyto-Src
Salubrinal and guanabenz is known to increase the phosphorylation level of eIF2a ( Fig. 2A, B) [28, 33] . To examine whether the inhibition of Src by salubrinal is associated with eIF2a, we employed eIF2a siRNA. The partial silencing of eIF2a abolished the inhibitory effect of salubrinal on Cyto-Src as compared to the cells treated with non-specific control siRNA (Fig. 4A) . However, salubrinal did not alter Lyn-Src activity by eIF2a siRNA (Fig. 4B) . Silencing eIF2a significantly decreased the basal level of Cyto-Src activity, but not that of Lyn-Src activity as compared to the NC siRNA-treated Src activity (Fig. 4C) .
Magnitude-dependent regulation of Lyn-Src by fluid flow
To determine whether mechanical stimulation affects Src activities, we applied uniform fluid flow with shear stress at 2, 5, or 10 dynes/cm 2 for 1 h. Lyn-Src was responsive to fluid flow in a magnitude-dependent manner (Fig. 5A) . In response to shear stress at 5 dynes/cm 2 , a rapid inhibition of Lyn-Src activity was observed (9.7% decrease). In contrast, shear stress at 10 dynes/ cm 2 led to its activation (14.9% increase). However, Cyto-Src activity was not altered at any magnitude of shear stress (Fig. 5B) .
Silencing eIF2a significantly reduced fluid flow-induced LynSrc activation, although eIF2a siRNA did not completely abolish the activation (3.9% increase at 60 min, Fig. 5C ). Note that transfection of NC siRNA led to a significant Lyn-Src activation by fluid flow (9.6% increase at 60 min). Unlike Lyn-Src, Cyto-Src in C28/I2 cells transfected with eIF2a or NC siRNA did not respond to fluid flow (Fig. 5D ). These results demonstrate that eIF2a is at least in part involved in the Lyn-Src response to fluid flow. To further examine the observed inhibitory effect of fluid flow at 5 dynes/cm 2 on Lyn-Src activities, we pretreated cells with TNFa or IL1b for 2 h before the application of fluid flow. Shear stress at 5 dynes/cm 2 substantially reduced the activation level of cytokine-induced Lyn-Src (TNFa: 10.1% decrease at 60 min; and IL1b: 6.5% decrease at 60 min) (Fig. 5E ).
Discussion
In this study we employed live cell imaging in conjunction with FRET-based Src biosensors to determine the spatiotemporal activities of Src in C28/I2 human chondrocytes. We used two types of the Src biosensors specific in the cytosol and lipid rafts of the plasma membrane. We first demonstrated that Src proteins in the cytosol and lipid rafts were activated by TNFa and IL1b with distinct dynamic patterns. Although the role of the inflammatory cytokines in regulating Src activation has been documented [44] , its spatiotemporal activation pattern has not been known. We observed that the cytokine-induced Src activation occurred earlier in the cytosol than that in the lipid raft region of the plasma membrane. Since it is considered that Src activation requires its translocation to the plasma membrane via the actin cytoskeleton [43] , our observations suggest that upon stimulation, Src moves quicker to the non-lipid rafts than to the lipid rafts of the plasma membrane. Taken together, the result is consistent with previous studies showing that translocation of Src from the cytosol to the non-raft region is faster than that to the raft region of the plasma membrane [45, 46] .
It has been reported that TNFa and IL1b differently affect degenerative joint diseases such as osteoarthritis [47, 48] . However, their differential effects on Src activity are not known. We observed that Cyto-Src activities by TNFa were significantly higher than those by IL1b, while Lyn-Src activities under the two cytokines were not significantly different. Although the exact mechanism is not clear, it is possible that Cyto-Src and Lyn-Src would differently interact with inflammatory signaling components, such as TNF receptor DEATH domain (TRADD) [49] , TRAF2 [50] , and GRB2 [51] . Another possibility is that TNFa would stimulate the release of IL1b [52] , which may further increase TNFa-induced Cyto-Src activity. In this study, however, the primary aim was to evaluate the role of mechanical force and salubrinal in the cytokine-induced Src. Investigating Src responses to different cytokines or interaction between TNFa and IL1b is an important subject. Further consideration is necessary to elucidate the molecular mechanism underlying the differential Src activities at different subcellular locations in response to various cytokines.
There are several lines of evidence that Src can be activated at the different locations within the cell, such as in the cytoplasm, along the actin cytoskeleton, or on the plasma membrane [24, 32, 43, 53] . Thus, we evaluated the possibility that Src may be activated in the cytoplasm before it is mobilized to the cell periphery or plasma membrane upon cytokine stimulation. To test this possibility, we disrupted the actin cytoskeleton and monitored Src activity in the cytosol and lipid rafts of the plasma membrane. While disruption of the actin cytoskeleton using cytochalasin D blocked Src activation in the lipid rafts, it did not completely inhibit cytosolic Src activation, suggesting that some population of cytosolic Src may be activated in the cytoplasm, without translocation through the actin cytoskeleton (Fig. 6) . These results support the previous findings that activation of Src at the lipid rafts of the plasma membrane requires its translocation through the actin cytoskeleton [53] and that Src can be activated in the cytoplasm [24, 32] . However, our data cannot distinguish whether cytosolic Src near the plasma membrane outside the lipid rafts, which may not require translocation, is activated or other focal adhesion proteins at the plasma membrane, such as vinculin [54] or talin [55] , are involved in this cytosolic Src activation. Further studies are needed to elucidate the underlying mechanism for this dynamically distinct Src activation at different cellular compartments.
We have previously reported that the inhibition of ER stress through eIF2a phosphorylation can decrease expression and activity of degrading enzymes such as MMP13 in C28/I2 human chondrocytes [29] . Here, we used two inhibitors for eIF2a dephosphorylation, salubrinal and guanabenz, and tested whether alleviating ER stress by eIF2a phosphorylation could attenuate the inflammatory cytokine-induced Src activation. We observed that the cytokine-induced Src in the cytosol, but not in the lipid rafts of the plasma membrane, was inhibited by salubrinal or guanabenz. This result suggests that Src at different compartments within the cell may be regulated by different mechanisms; cytosolic Src is downregulated by eIF2a phosphorylation, but Src in the lipid rafts may not be a critical signaling node within an ER stress signaling pathway (Fig. 6) .
Our results further suggest that these distinct responses of Src activities are differently regulated by fluid flow. In contrast to the nonresponsive Src activity in the lipid rafts of the plasma membrane by salubrinal or guanabenz, fluid flow-induced shear stress (5 dynes/cm 2 ) was able to significantly inhibit the cytokineinduced Src activity at the lipid rafts. This result is consistent with previous findings that lipid rafts of the plasma membrane are involved in Src mechanotransduction [31, 56] . On the contrary, cytosolic Src was not responsive to the shear stress. We previously reported that local mechanical force applied from the cell surface using a small (4.5 mm in diameter) magnetic bead induces highly localized cytosolic Src activity and does not yield global FRET changes of the Src biosensors within the cytoplasm [32] . We do not know whether cytosolic Src does not respond to shear stress that is evenly distributed over the cell surface, or activation of the cytosolic Src by shear stress is not sufficient to yield detectable FRET changes from a substantial pool of Src biosensors in the cytosol [31] . We also observed that Src activities at the lipid rafts of the plasma membrane are selectively up-or down-regulated by ) shear stress decrease and increase Src activity in the lipid rafts, respectively. This result is consistent with previous reports on fluid flow magnitude-dependent small GTPase RhoA activities [37] and MMP13 activities [57] in chondrocytes.
In summary, our findings of the distinct activation patterns of Src kinases suggest the critical role of mechanical loading and inhibition of ER stress through phosphorylation of eIF2a in arthritic cartilage (Fig. 6) . By selectively regulating subcellular Src kinases, fluid flow and a chemical agent that inhibits ER stress appear to interact with Src-dependent regulatory pathways important for chondrogenesis and cartilage maintenance [25, 58] . The work herein suggests that a proper combination of chemical and mechanical stimuli may present a potential therapeutic strategy for prevention of cartilage loss in joint diseases such as OA. Further study on the signaling pathways connecting subcellular Src kinases to proteolytic gene expression in chondrocytes may benefit in developing a therapeutic strategy for joint diseases. 
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